Patents Examined by Gina C Justice
  • Patent number: 10543171
    Abstract: The invention generally relates to the field of drug delivery. In particular, the invention relates to amphiphilic dendron-coils, micelles thereof and their use for the transdermal delivery of drugs.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: January 28, 2020
    Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventors: Seungpyo Hong, Yang Yang
  • Patent number: 10542757
    Abstract: The present invention relates to a composition comprising at least one biological control agent. Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: January 28, 2020
    Assignee: Bayer CropScience AG
    Inventors: Elke Hellwege, Wolfram Andersch, Klaus Stenzel, Bernd Springer
  • Patent number: 10525065
    Abstract: Method and composition for treating psoriasis and other skin disorders.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: January 7, 2020
    Assignee: ANAPLASI PHARMACEUTICALS, LLC
    Inventor: Edward Richard Yuhas
  • Patent number: 10525087
    Abstract: The present invention is related to methods of making crustacean oil compositions. In particular, the crustacean oil compositions are krill oil compositions. In some embodiments, the krill oil compositions are concentrated in phospholipids. These concentrated phospholipid krill oil compositions have a sufficient flowability to permit successful encapsulation at phospholipid concentrations that is currently unattainable in the art. Such phospholipid krill oil compositions are capable of encapsulation even though they may have a phospholipid concentration ranging between approximately 60%-99% and a viscosity ranging between 100,000-3,000,000 cP. Such concentrated phospholipid krill oil compositions may be created using a small molecule organic solvent/water extraction mixture and/or sub-critical or super-critical fluid extraction at low temperatures followed by a drying process to remove water and organic solvent (e.g., for example, ethanol).
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: January 7, 2020
    Assignee: Rimfrost Technologies AS
    Inventor: Inge Bruheim
  • Patent number: 10517998
    Abstract: The present invention relates to settable compositions for use in surgery. The invention also provides related compositions, including surgical kits and packages, as well as methods of making and using the settable compositions.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: December 31, 2019
    Assignee: Abyrx, Inc.
    Inventors: John Pacifico, Aniq Darr, Richard L. Kronenthal
  • Patent number: 10507204
    Abstract: The present invention relates to a pharmaceutical composition comprising an amorphous adsorbate of lenalidomide, or a pharmaceutically acceptable salt thereof, on a porous carrier and one or more pharmaceutically acceptable excipients. The invention further relates to the use of said composition as a medicament, particularly in the treatment of multiple myeloma and myelodysplastic syndromes.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: December 17, 2019
    Assignee: Synthon B.V.
    Inventors: Deepak Murpani, Marta Vivancos Martinez, Lisardo Alvarez Fernandez, Luis Nogueiras Nieto
  • Patent number: 10507173
    Abstract: This invention relates to an odour-absorbing composition comprising a mixture of ?-, ?-, and ?-cyclodextrins, wherein the amount of one of said ?-, ?-, and ?-cyclodextrins is equal to or higher than the total amount of the other two cyclodextrins.
    Type: Grant
    Filed: June 21, 2016
    Date of Patent: December 17, 2019
    Assignee: AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A.
    Inventors: Serena Tongiani, Lorella Ragni, Daniela Donelli
  • Patent number: 10485754
    Abstract: The process serves for preparing sodium ion-free X carbonate or hydrogencarbonate effervescent powder, such granules or such tablets. The active substances X, at least calcium carbonate, moistened with a small amount of alcohol and water, are mixed as powder with a small amount of lactobionic acid in a partial vacuum in a vacuum tank with continual pumping. As a result, the calcium salt (CaCO3) of the calcium in the surface layer of the powder particles reacts with the lactobionic acid, effervesces and releases a small amount of CO2. Consequently, the pressure in the vacuum tank rises and after the end of the effervescent reaction the internal pressure in the vacuum tank drops back to the starting value through the continual pumping. In so doing, the powder dries. After removal from the vacuum chamber an acid, preferably citric acid, as an effervescing agent is added, and subsequently the powder is electively pressed into tablets.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: November 26, 2019
    Assignee: BIOFAR LABORATORIES
    Inventor: Hanspeter Strobel
  • Patent number: 10485894
    Abstract: A formed sheet product of a polymer composition comprising at least one protein selected from the group consisting of fibrinogen and thrombin and at least one polymer selected from the group consisting of an aliphatic polyester and a water-soluble polymer, and a laminated formed sheet product comprising a first polymer composition layer composed of fibrinogen and a water-soluble polymer and a second polymer composition layer composed of thrombin and an aliphatic polyester are provided. These formed products are applied onto a wound site and function as a hemostatic material.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: November 26, 2019
    Assignees: TEIJIN LIMITED, Teijin Pharma Limited, KM BIOLOGICS CO., LTD.
    Inventors: Yukako Kageyama, Kentaro Fujinaga, Ayuko Yamaguchi, Yusuke Akiyama, Akitoshi Oono, Susumu Honda, Makoto Satake, Hiroaki Kaneko, Takayuki Imamura, Ryoichi Kawamura, Masaki Hirashima
  • Patent number: 10485750
    Abstract: The instant disclosure relates to solid hair-styling compositions that have a unique physical appearance and provide desirable styling benefits to the hair. The solid hair-styling compositions are in the form of translucent, rock candy-like (or glass-like) crystals, which are visually striking. Major components of the solid hair-styling compositions include polyvinylpyrrolidone and polyquaternium-28. The amount of water in the compositions, if present, is kept at a minimum to ensure crystallinity. In addition to their aesthetic appeal, the solid hair-styling compositions provide a variety of hair-styling benefits such as hold, shine, and conditioning to hair.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: November 26, 2019
    Assignee: L'OREAL
    Inventors: Santiago Uribe, Azizah Suleiman, Anand Mahadeshwar
  • Patent number: 10471178
    Abstract: The present invention relates to the contacting of one or more surfaces of an implantable medical device with one or more diketopiperazines (DKPs).
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: November 12, 2019
    Assignee: Ampio Pharmaceuticals, Inc.
    Inventor: David Bar-Or
  • Patent number: 10471071
    Abstract: The present invention is directed to orally administered compositions of topically acting corticosteroids for the treatment of inflammation of the gastrointestinal tracts such as eosinophilic esophagitis. The present invention also provides a method for treating conditions associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention as orally disintegrating tablets comprising a topically active corticosteroid adsorbed onto a pharmaceutically acceptable carrier such as silicified microcrystalline cellulose.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: November 12, 2019
    Assignee: Adare Pharmaceuticals, Inc.
    Inventors: Michael A. Gosselin, Jin-Wang Lai, Gopi M. Venkatesh
  • Patent number: 10470480
    Abstract: The present invention pertains to a method for manufacturing a feed product comprising the steps of: providing a lactylate product, wherein the lactylate product comprises at least 30 wt. % of C10-C16-fatty acid lactylates, in liquid form at a first location; transferring lactylate product in the liquid form to a transport unit; transporting the lactylate product in the transport unit to a second location, with the lactylate product being in solid form, in liquid form, or in an intermediate state during transport; if the lactylate product is solidified or partly solidified, converting the lactylate product to the liquid form in the transport unit; removing the lactylate product from the transport unit in liquid form at the second location; and, contacting the lactylate product in liquid form with a feed product.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: November 12, 2019
    Assignee: PURAC BIOCHEM B.V.
    Inventors: Nikolaos Vogiatzis, Symone Kok, Barbara Lara Veldhuis-Stribos
  • Patent number: 10472237
    Abstract: An aqueous composition includes an activator, a chlorite ion source, and water. The aqueous composition is alkaline. The aqueous composition produces chlorine dioxide upon contact with an acid. A method of producing chlorine dioxide includes contacting the aqueous composition with an acid.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: November 12, 2019
    Assignee: DIVERSEY, INC.
    Inventors: Henry von Rege, Ingo Mistele
  • Patent number: 10463676
    Abstract: The present invention relates to methods for weight management that utilize modified-release dosage forms comprising (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts and crystalline forms thereof. The present invention further relates to (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts, crystalline forms thereof and modified-release dosage forms comprising them.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: November 5, 2019
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Zezhi Jesse Shao, Anthony C. Blackburn, Andrew J. Grottick, Michael E. Morgan, Jaimie Karyn Rueter, Anna Shifrina, Scott Stirn, Libo Yang, Woo Hyun Yoon
  • Patent number: 10448643
    Abstract: The invention provides for a low pH disinfectant composition that includes a relatively low amount of alcohol. Also provided is an article of manufacture that includes a textile and the composition, as well as methods of using the composition and article of manufacture (e.g., for reducing the number of microbes located upon a substrate, for killing or inhibiting a broad spectrum of microorganisms, for killing or inhibiting spore forming bacteria, and/or for disinfecting a substrate). The composition can optionally include a stable residual antimicrobial compound, thereby providing a combination of high-level disinfection and long-lasting residual effect.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: October 22, 2019
    Assignee: Medivators Inc.
    Inventors: Huyen Phuong Bui, Adam W. Hauser, Thomas M. Gentle, Jonathan K. Olson, John J. Matta
  • Patent number: 10449136
    Abstract: The invention provides a hair shaping composition suitably for topical application to hair, the composition having a pH of 4 or less and comprising, in an aqueous continuous phase: (i) at least 0.5% by weight based on the total weight of the composition of a first component selected from D-glucono-?-lactone, D-glucono-?-lactone, D-gluconic acid and mixtures thereof; (ii) at least 0.1% by weight based on the total weight of the composition of a second component selected from glyoxylic acid, glyoxylic acid hydrate, salts thereof and mixtures thereof; in which the weight ratio of first component (i) to second component (ii) in the hair shaping composition ranges from 10:1 to 1:10.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: October 22, 2019
    Assignee: CONOPCO, INC.
    Inventors: Prem Kumar Cheyalazhagan Paul, Charlotte Breony Tandy Rogers
  • Patent number: 10441539
    Abstract: The invention relates in particular to an injectable sclerosant drug foam comprising: (i) a matrix; (ii) at least one fluid; (iii) at least one sclerosant drug; (iv) a medical gas or medical gas mixture acceptable for intravenous use, (v) wherein said matrix has physical properties, which are comparable to denatured blood, wherein the denatured blood is obtainable from a fresh human venous whole blood sample of 1 ml volume, which is heated in a cylindrical polyethylene container with 3 mm inner diameter and 3.4 mm outer diameter for about 0.5 min. to about 10 min. at a temperature of about between 70° C. and 100° C. and/or (vii) said level of denaturation is defined by the change of red-colored hemoglobin to brown as an indicator, wherein Fe2+ is reduced to Fe3+ in the hemoglobin complex to a degree of at least 80%, preferably 90% and even more preferably 95%.
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: October 15, 2019
    Assignee: SWISS VX VENENTHERAPIE UND FORSCHUNG GMBH
    Inventor: Johann Christof Ragg
  • Patent number: 10441526
    Abstract: A liquid oil dispersion cosmetic composition of the present invention is capable of implementing a refreshing and light feeling and has excellent dispersibility by containing surfactants, powders, and volatile substances having fast volatility, low viscosity and low density. In addition, the liquid oil dispersion cosmetic composition, according to the present invention, can prevent precipitation of the powders by being uniformly impregnated in between the pores of foam carriers, and thus, can maintain high formulation stability even during long-term storage.
    Type: Grant
    Filed: June 21, 2016
    Date of Patent: October 15, 2019
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Se Rim Yoon, Kyung Nam Kim, Kyung Ho Choi, Yeong Jin Choi
  • Patent number: 10406083
    Abstract: A cosmetic having excellent properties in transparency, spreadability, smoothness, skin compatibility and safety is prepared using a synthetic talc that is flake-like particles containing 2:1-type laminar crystals of silicate which have a basic structure of an octahedron sheet sandwiched between two tetrahedron sheets. The flake-like particle has a mean volume particle diameter of 0.5 to 100 ?m, and 0.3° or less of half width at half maximum of peak present at 2? equal to 9.4°±1° when measured by unoriented powder X-ray diffractometry (XRD) using CuK? rays, and the cosmetic is substantially free of Mg3Si2O5(OH)4.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: September 10, 2019
    Assignee: JO Cosmetics Co., Ltd.
    Inventor: Hiroko Kimura